Liao_2023_Trends.Biochem.Sci__

Reference

Title : Microbial gatekeepers: unraveling the role of the gut microbiota enzyme DPP4 in diabetes management - Liao_2023_Trends.Biochem.Sci__
Author(s) : Liao L , Lin F , Gao J
Ref : Trends in Biochemical Sciences , : , 2023
Abstract :

Wang et al. identified dipeptidyl peptidase 4 (DPP4) as a gut microbe-derived enzyme that impacts on host glucose metabolism. They further introduced a novel therapeutic, daurisoline-d4 (Dau-d4), a selective microbial DPP4 (mDPP4) inhibitor that shows promise in improving glucose tolerance, highlighting the potential of therapies that target both host enzymes and gut microbial enzymes.

PubMedSearch : Liao_2023_Trends.Biochem.Sci__
PubMedID: 37770288

Related information

Inhibitor O-Methyl-Dauracine

Citations formats

Liao L, Lin F, Gao J (2023)
Microbial gatekeepers: unraveling the role of the gut microbiota enzyme DPP4 in diabetes management
Trends in Biochemical Sciences :

Liao L, Lin F, Gao J (2023)
Trends in Biochemical Sciences :